LUNG Q3 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$72M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+25.0% YoY

Gross Profit

$10M73.4% margin

Operating Income

-$10M-73.6% margin

Net Income

-$10M-76.8% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$247M

Total Liabilities

$44M

Stockholders' Equity

$203M

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+25.0%
Gross Profit	$10M	$7M	+30.5%
Operating Income	-$10M	-$5M	-82.5%
Net Income	-$10M	-$4M	-163.8%

Geographic Segments

UNITED STATES

$7M52%

EMEA

$6M42%

Asia Pacific

$756,0006%

Other International Geographical Areas

$37,0000%